New vaccine aims to block more Cancer-Causing HPV strains
Prevention
Ongoing
This large Phase 3 trial is testing a new 9-valent HPV vaccine designed to protect against nine types of human papillomavirus. It aims to prevent cervical cancer, precancerous lesions, and genital warts in healthy women aged 18 to 45. The study compares the new vaccine's effectiv…
Phase: PHASE3 • Sponsor: Xiamen University • Aim: Prevention
Last updated Apr 20, 2026 16:19 UTC